CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...
After a diagnosis of long COVID, patients in Colorado shifted from seeking care in hospitals and emergency departments (EDs) ...
A violinist plays for her father. A singer takes requests. In hospitals and hospices, bedside performers offer a new kind of ...
Following recent reports on the rise in corridor care and growing A&E waits, many are concerned by the devastating collapse ...
17hon MSN
What we heard from patients and staff across the country exposes a system under extreme and unsustainable pressure where the wellbeing of both patients and healthcare professionals is at significant r ...
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
If you have a new pain or injury, you do not have to wait to see the experts, thanks to the OSMS Acute Injury Walk-In Clinic. In this segment, Matt Christianson, the father of a patient at ...
ORLADEYO ® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary ...
Pneumonia is swelling (inflammation) of the tissue in one or both lungs. According to the NHS, it's usually caused by a ...
Though long COVID, or post-acute sequelae of SARS-CoV-2 (PASC), is more common in adults than in kids, 1.3% of US children ...
In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback